Editöre Mektup

Percutaneous closure should be given a chance in patent ductus arteriosus with severe pulmonary hypertension

Cilt: 45 Sayı: 2 30 Haziran 2020
Ömer Tepe *, Çağlar Özmen , Ali Deniz , Nazan Özbarlas , Mehmet Topçuoğlu
PDF İndir
EN TR

Percutaneous closure should be given a chance in patent ductus arteriosus with severe pulmonary hypertension

Abstract

-

Kaynakça

  1. Grifka RG. Transcatheter closure of the patent ductus arteriosus. Catheter Cardiovasc Interv. 2004;61:554-70. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139:e637–97. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010) Eur Heart J. 2010;31:2915–57. Fisher RG, Moodie DS, Sterba R, Gill CC. Patent ductus arteriosus in adults – Long-term follow-up: Nonsurgical versus surgical treatment. J Am Coll Cardiol. 1986;8:280–4.

Kaynak Göster

MLA
Tepe, Ömer, vd. “Percutaneous closure should be given a chance in patent ductus arteriosus with severe pulmonary hypertension”. Cukurova Medical Journal, c. 45, sy 2, Haziran 2020, ss. 758-9, doi:10.17826/cumj.667803.